Scientists in Indonesia have reported that only one in five Indonesian women are aware of cervical cancer screening, while only five percent of women are aware of breast cancer screening.
Ivermectin, a drug used to treat parasitic infections, has been found to be useful in the treatment of ovarian cancer.
Clearbridge BioMedics is the first Asian biotechnology company to join the CANCER-ID consortium for blood-based biomarker evaluation.
By analyzing body mass index and waist-hip ratio, scientists in China have discovered that the location of body fat is linked to specific breast cancer subtypes.
Researchers have grown micro-tumor models using patients’ cancer cells to identify more effective treatments for drug-resistant tumors.
Nearly half of cancer deaths in China are attributable to potentially modifiable risk factors such as smoking or alcohol use.
Researchers have found that the levels of a protein called BCL6 can be used to identify patients with glioblastoma multiforme, a particularly aggressive type of brain cancer.
GRAIL and Cirina have entered an agreement to form a global company focused on the early detection of cancer.
Two studies from Singapore have shown that a personalized approach could benefit patients suffering from cancer.